107 related articles for article (PubMed ID: 22882692)
1. Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients.
Salles MJ; Sens YA; Malafronte P; Souza JF; Vilas Boas LS; Machado CM
Transpl Infect Dis; 2012 Dec; 14(6):564-74. PubMed ID: 22882692
[TBL] [Abstract][Full Text] [Related]
2. Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults.
Crum-Cianflone NF; Iverson E; Defang G; Blair PJ; Eberly LE; Maguire J; Ganesan A; Faix D; Duplessis C; Lalani T; Whitman T; Brandt C; Macalino G; Millar EV; Burgess T
Vaccine; 2011 Apr; 29(17):3183-91. PubMed ID: 21371580
[TBL] [Abstract][Full Text] [Related]
3. Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals.
Ho J; Moir S; Wang W; Posada JG; Gu W; Rehman MT; Dewar R; Kovacs C; Sneller MC; Chun TW; Follmann DA; Fauci AS
AIDS; 2011 Jan; 25(3):295-302. PubMed ID: 21157297
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.
Skowronski DM; Janjua NZ; De Serres G; Hottes TS; Dickinson JA; Crowcroft N; Kwindt TL; Tang P; Charest H; Fonseca K; Gubbay JB; Bastien N; Li Y; Petric M
BMJ; 2011 Feb; 342():c7297. PubMed ID: 21292718
[TBL] [Abstract][Full Text] [Related]
5. Influence of renal replacement therapy on immune response after one and two doses of the A(H1N1) pdm09 vaccine.
Quintana LF; Serra N; De Molina-Llauradó P; Blasco M; Martinez M; Campos B; Bayas JM; Pumarola T; Campistol JM
Influenza Other Respir Viruses; 2013 Sep; 7(5):809-14. PubMed ID: 23078139
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine.
Busse WW; Peters SP; Fenton MJ; Mitchell H; Bleecker ER; Castro M; Wenzel S; Erzurum SC; Fitzpatrick AM; Teague WG; Jarjour N; Moore WC; Sumino K; Simeone S; Ratanamaneechat S; Penugonda M; Gaston B; Ross TM; Sigelman S; Schiepan JR; Zaccaro DJ; Crevar CJ; Carter DM; Togias A
J Allergy Clin Immunol; 2011 Jan; 127(1):130-7, 137.e1-3. PubMed ID: 21145578
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients.
Miraglia JL; Abdala E; Hoff PM; Luiz AM; Oliveira DS; Saad CG; Laurindo IM; Viso AT; Tayra A; Pierrotti LC; Azevedo LS; Campos LM; Aikawa NE; Timenetsky Mdo C; Luna E; Cardoso MR; Guedes Jda S; Raw I; Kalil J; Precioso AR
PLoS One; 2011; 6(11):e27214. PubMed ID: 22087267
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns.
Helmig RB; Maimburg RD; Erikstrup C; Nielsen HS; Petersen OB; Nielsen LP; Hvidman L; Veirum JE; Henriksen TB; Storgaard M
Acta Obstet Gynecol Scand; 2015 Aug; 94(8):833-9. PubMed ID: 25958884
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus.
Aikawa NE; Borba EF; Balbi VA; Sallum AME; Buscatti IM; Campos LMA; Kozu KT; Garcia CC; Capão ASV; de Proença ACT; Leon EP; da Silva Duarte AJ; Lopes MH; Silva CA; Bonfá E
Adv Rheumatol; 2023 Nov; 63(1):55. PubMed ID: 38017564
[TBL] [Abstract][Full Text] [Related]
10. Assessment of parental report for 2009-2010 seasonal and monovalent H1N1 influenza vaccines among children in the emergency department or hospital.
Poehling KA; Vannoy L; Light LS; Suerken CK; Snively BM; Guitierrez A; Peters TR
Acad Pediatr; 2012; 12(1):36-42. PubMed ID: 22033102
[TBL] [Abstract][Full Text] [Related]
11. Low seroconversion after one dose of AS03-adjuvanted H1N1 pandemic influenza vaccine in solid-organ transplant recipients.
Resende MR; Husain S; Gubbay J; Singer L; Cole E; Renner EL; Rotstein C
Can J Infect Dis Med Microbiol; 2013; 24(1):e7-e10. PubMed ID: 24421799
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of immunogenicity and safety of two versus single-doses of influenza A (H1N1) vaccine in person living with HIV.
Zhang T; Geng J; Du Y; Yang H; Jin Y; Chen S; Duan G
Int J STD AIDS; 2024 Apr; 35(5):326-336. PubMed ID: 38087772
[No Abstract] [Full Text] [Related]
13. Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events.
Sobolev O; Binda E; O'Farrell S; Lorenc A; Pradines J; Huang Y; Duffner J; Schulz R; Cason J; Zambon M; Malim MH; Peakman M; Cope A; Capila I; Kaundinya GV; Hayday AC
Nat Immunol; 2016 Feb; 17(2):204-13. PubMed ID: 26726811
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Vaccine Seroresponse Based on The Timing of The Primary Series; Pre- versus Post-Renal Transplantation.
Weinberg AR; Caeg CO; DePalma R; Hernandez F; Rogers JH; Ibrahim HN; Bynon SJ; Nigo M
Clin Transplant; 2023 Nov; 37(11):e15072. PubMed ID: 37434417
[TBL] [Abstract][Full Text] [Related]
15. Adjuvanted Influenza Vaccines Elicits Higher Antibody Responses against the A(H3N2) Subtype than Non-Adjuvanted Vaccines.
Sánchez de Prada L; Sanz Muñoz I; Castrodeza Sanz J; Ortiz de Lejarazu Leonardo R; Eiros Bouza JM
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33255600
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum: Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events.
Sobolev O; Binda E; O'Farrell S; Lorenc A; Pradines J; Huang Y; Duffner J; Schulz R; Cason J; Zambon M; Malim MH; Peakman M; Cope A; Capila I; Kaundinya GV; Hayday AC
Nat Immunol; 2016 Apr; 17(4):469. PubMed ID: 27002849
[No Abstract] [Full Text] [Related]
17. Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial.
Le Corre N; Thibault F; Pouteil Noble C; Meiffrédy V; Daoud S; Cahen R; Charreau I; Bottigioli D; Dollinger C; Aboulker JP; Autran B; Morelon E; Barrou B
Vaccine; 2012 Dec; 30(52):7522-8. PubMed ID: 23103195
[TBL] [Abstract][Full Text] [Related]
18. Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients.
Fernández-Ruiz M; Lumbreras C; Arrazola MP; López-Medrano F; Andrés A; Morales JM; de Juanes JR; Aguado JM
Transpl Infect Dis; 2015 Apr; 17(2):314-21. PubMed ID: 25728936
[TBL] [Abstract][Full Text] [Related]
19. Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors.
Azevedo LS; Gerhard J; Miraglia JL; Precioso AR; Tavares Timenetsky MD; Agena F; Gamba C; Shikanai Yasuda MA; David-Neto E; Pierrotti L
Transpl Infect Dis; 2013 Dec; 15(6):612-8. PubMed ID: 24134688
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against Streptococcus pneumoniae does not induce antibodies against HLA or MICA in clinically stable kidney transplant recipients.
Lindemann M; Heinemann FM; Horn PA; Witzke O
Hum Immunol; 2013 Oct; 74(10):1267-70. PubMed ID: 23911739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
